CD22 targeting-moiety for the treatment of B-cell acute lymphoblastic leukemia (B-ALL)
US-12522666-B2 · Jan 13, 2026 · US
Inst Catalana De Recerca I Estudis Avancats Icrea holds 18 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 18 |
| Recent patents | 7 |
| First publication | Feb 15, 2018 |
| Latest publication | Jan 13, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12522666-B2 · Jan 13, 2026 · US
US-12397497-B2 · Aug 26, 2025 · US
US-2025085575-A1 · Mar 13, 2025 · US
US-2024327275-A1 · Oct 3, 2024 · US
US-2024038044-A1 · Feb 1, 2024 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12522666-B2 · Jan 13, 2026 · US
US-12397497-B2 · Aug 26, 2025 · US
US-2025085575-A1 · Mar 13, 2025 · US
US-2024327275-A1 · Oct 3, 2024 · US
US-2024038044-A1 · Feb 1, 2024 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 9 |
| Physics | 7 |
| Operations & Transport | 6 |
| Electricity | 5 |
| Human Necessities | 4 |
| Cross-Sectional Technologies | 4 |
Answers are generated from the same data shown on this page.